Main > ONCOLOGY (**) > Liver Cancer *** > Treatment. > USA. G. HCC>TREAT.>AtezolizuMAb+



USA. G. HCC>TREAT.>AtezolizuMAb+'s subsections
(*) CN Approval Date: 2020. 10.29
+BevacizuMAb
Company
Patent>Assignee; Claims; No.; Etc.
TradeMark
TradeMark Web-Site

USA. G. HCC>TREAT.>AtezolizuMAb+'s products
This section has no products